Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes

Area of Science:

• Oncology
• Genomics
• Translational Medicine

Background:

• Precision oncology aims to customize cancer treatment based on individual molecular and biological features.
• Technological advances in genomic sequencing and targeted therapies are driving the implementation of precision oncology.
• Metastatic malignancies present complex, heterogeneous molecular landscapes that differ significantly between patients.

Purpose of the Study:

• To highlight the disruptive impact of next-generation sequencing on traditional clinical research paradigms.
• To advocate for a paradigm shift towards patient-centered, N-of-one approaches in precision oncology.
• To address the challenges posed by molecular heterogeneity in advanced cancers.

Main Methods:

• Review of current literature on precision oncology and genomic sequencing.
• Analysis of the implications of tumor heterogeneity for clinical trial design.
• Conceptual framework development for N-of-one treatment strategies.

Main Results:

• Next-generation sequencing reveals significant molecular heterogeneity in advanced tumors, challenging traditional grouping methods.
• Classic drug-centered research models are ill-suited for the unique molecular profiles of individual metastatic cancer patients.
• The complexity of metastatic malignancies necessitates a move away from broad patient stratification.

Conclusions:

• A patient-centered, N-of-one approach is required for effective precision oncology in metastatic cancer.
• Individually tailored treatments are essential given the unique molecular portfolios of each patient.
• The future of oncology research and practice must adapt to embrace personalized medicine.